Jacobs Levy Equity Management, Inc Ideaya Biosciences, Inc. Transaction History

Jacobs Levy Equity Management, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$13.33 - $25.53 $172,570 - $330,511	-12,946 Reduced 57.71%	9,486 $222,000
Q1 2023 May 15, 2023	BUY	$13.49 - $18.72 $302,607 - $419,927	22,432 New	22,432 $307,000
Q4 2020 Feb 16, 2021	SELL	$12.17 - $17.52 $502,292 - $723,102	-41,273 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$11.22 - $14.46 $175,525 - $226,212	-15,644 Reduced 27.49%	41,273 $518,000
Q2 2020 Aug 17, 2020	BUY	$3.59 - $18.57 $142,185 - $735,483	39,606 Added 228.79%	56,917 $809,000
Q1 2020 May 15, 2020	SELL	$3.03 - $10.58 $8,505 - $29,698	-2,807 Reduced 13.95%	17,311 $71,000
Q4 2019 Feb 14, 2020	BUY	$5.34 - $9.09 $107,430 - $182,872	20,118 New	20,118 $151,000

216

80.8M

69K

20K

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $1.33B
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.